vs
Side-by-side financial comparison of BridgeBio Pharma, Inc. (BBIO) and Forestar Group Inc. (FOR). Click either name above to swap in a different company.
Forestar Group Inc. is the larger business by last-quarter revenue ($273.0M vs $154.2M, roughly 1.8× BridgeBio Pharma, Inc.). Forestar Group Inc. runs the higher net margin — 5.6% vs -126.2%, a 131.9% gap on every dollar of revenue. On growth, BridgeBio Pharma, Inc. posted the faster year-over-year revenue change (2521.2% vs 9.0%). BridgeBio Pharma, Inc. produced more free cash flow last quarter ($-56.5M vs $-157.1M).
Brent Saunders is an American biopharma executive and entrepreneur who is the chairman and CEO of the health company Bausch & Lomb. He helped lead various mergers and acquisitions, including the mergers between Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He founded the special-purpose acquisition company (SPAC) Vesper Healthcare Acquisition. Saunders is also executive chairman of medical aesthet...
Forestar Group Inc. is a residential lot development company based in Arlington, Texas. The company has operations in 51 markets in 21 states and delivered 11,518 residential lots during the twelve-month period ended December 31, 2020. The company is publicly traded on the New York Stock Exchange and in October 2017 became a majority-owned subsidiary of D.R. Horton, Inc., the largest homebuilder by volume in the United States since 2002. The company primarily acquires entitled real estate and...
BBIO vs FOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $154.2M | $273.0M |
| Net Profit | $-194.6M | $15.4M |
| Gross Margin | 94.7% | 20.1% |
| Operating Margin | -90.5% | 7.6% |
| Net Margin | -126.2% | 5.6% |
| Revenue YoY | 2521.2% | 9.0% |
| Net Profit YoY | 27.2% | -6.7% |
| EPS (diluted) | $-1.00 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $154.2M | $273.0M | ||
| Q3 25 | $120.7M | $670.5M | ||
| Q2 25 | $110.6M | $390.5M | ||
| Q1 25 | $116.6M | $351.0M | ||
| Q4 24 | — | $250.4M | ||
| Q3 24 | — | $551.3M | ||
| Q2 24 | — | $318.4M | ||
| Q1 24 | $211.1M | $333.8M |
| Q4 25 | $-194.6M | $15.4M | ||
| Q3 25 | $-184.9M | $86.9M | ||
| Q2 25 | $-183.8M | $32.9M | ||
| Q1 25 | $-169.6M | $31.6M | ||
| Q4 24 | — | $16.5M | ||
| Q3 24 | — | $81.5M | ||
| Q2 24 | — | $38.7M | ||
| Q1 24 | $-36.2M | $45.0M |
| Q4 25 | 94.7% | 20.1% | ||
| Q3 25 | 94.6% | 22.3% | ||
| Q2 25 | 96.7% | 20.4% | ||
| Q1 25 | 97.7% | 22.6% | ||
| Q4 24 | — | 22.0% | ||
| Q3 24 | — | 23.9% | ||
| Q2 24 | — | 22.5% | ||
| Q1 24 | 99.7% | 24.9% |
| Q4 25 | -90.5% | 7.6% | ||
| Q3 25 | -120.3% | 16.9% | ||
| Q2 25 | -121.4% | 11.2% | ||
| Q1 25 | -89.5% | 11.6% | ||
| Q4 24 | — | 8.7% | ||
| Q3 24 | — | 19.7% | ||
| Q2 24 | — | 16.2% | ||
| Q1 24 | 0.2% | 17.6% |
| Q4 25 | -126.2% | 5.6% | ||
| Q3 25 | -153.2% | 13.0% | ||
| Q2 25 | -166.2% | 8.4% | ||
| Q1 25 | -145.4% | 9.0% | ||
| Q4 24 | — | 6.6% | ||
| Q3 24 | — | 14.8% | ||
| Q2 24 | — | 12.2% | ||
| Q1 24 | -17.1% | 13.5% |
| Q4 25 | $-1.00 | $0.30 | ||
| Q3 25 | $-0.95 | $1.70 | ||
| Q2 25 | $-0.95 | $0.65 | ||
| Q1 25 | $-0.88 | $0.62 | ||
| Q4 24 | — | $0.32 | ||
| Q3 24 | — | $1.59 | ||
| Q2 24 | — | $0.76 | ||
| Q1 24 | $-0.20 | $0.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $570.1M | $211.7M |
| Total DebtLower is stronger | $2.0B | $793.2M |
| Stockholders' EquityBook value | $-2.1B | $1.8B |
| Total Assets | $936.0M | $3.2B |
| Debt / EquityLower = less leverage | — | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $570.1M | $211.7M | ||
| Q3 25 | $643.0M | $379.2M | ||
| Q2 25 | $756.9M | $189.2M | ||
| Q1 25 | $540.6M | $174.3M | ||
| Q4 24 | — | $132.0M | ||
| Q3 24 | — | $481.2M | ||
| Q2 24 | — | $359.2M | ||
| Q1 24 | $519.7M | $416.2M |
| Q4 25 | $2.0B | $793.2M | ||
| Q3 25 | $2.0B | $802.7M | ||
| Q2 25 | — | $872.8M | ||
| Q1 25 | — | $872.5M | ||
| Q4 24 | — | $806.8M | ||
| Q3 24 | — | $706.4M | ||
| Q2 24 | — | $706.1M | ||
| Q1 24 | — | $705.7M |
| Q4 25 | $-2.1B | $1.8B | ||
| Q3 25 | $-1.9B | $1.8B | ||
| Q2 25 | $-1.8B | $1.7B | ||
| Q1 25 | $-1.6B | $1.6B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | $-1.0B | $1.5B |
| Q4 25 | $936.0M | $3.2B | ||
| Q3 25 | $998.3M | $3.1B | ||
| Q2 25 | $1.1B | $3.1B | ||
| Q1 25 | $881.6M | $3.0B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | — | $2.7B | ||
| Q1 24 | $849.3M | $2.6B |
| Q4 25 | — | 0.44× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.52× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.47× | ||
| Q1 24 | — | 0.48× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-56.4M | $-157.0M |
| Free Cash FlowOCF − Capex | $-56.5M | $-157.1M |
| FCF MarginFCF / Revenue | -36.6% | -57.5% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | -10.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $93.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-56.4M | $-157.0M | ||
| Q3 25 | $-109.6M | $256.3M | ||
| Q2 25 | $-80.7M | $15.8M | ||
| Q1 25 | $-199.2M | $-19.8M | ||
| Q4 24 | — | $-450.0M | ||
| Q3 24 | — | $119.2M | ||
| Q2 24 | — | $-61.7M | ||
| Q1 24 | $-219.5M | $-59.2M |
| Q4 25 | $-56.5M | $-157.1M | ||
| Q3 25 | $-110.0M | $255.6M | ||
| Q2 25 | $-81.3M | $15.0M | ||
| Q1 25 | — | $-20.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $118.4M | ||
| Q2 24 | — | $-62.3M | ||
| Q1 24 | $-220.2M | $-59.8M |
| Q4 25 | -36.6% | -57.5% | ||
| Q3 25 | -91.2% | 38.1% | ||
| Q2 25 | -73.5% | 3.8% | ||
| Q1 25 | — | -5.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 21.5% | ||
| Q2 24 | — | -19.6% | ||
| Q1 24 | -104.3% | -17.9% |
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.4% | 0.1% | ||
| Q2 25 | 0.5% | 0.2% | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | 0.3% | 0.2% |
| Q4 25 | — | -10.19× | ||
| Q3 25 | — | 2.95× | ||
| Q2 25 | — | 0.48× | ||
| Q1 25 | — | -0.63× | ||
| Q4 24 | — | -27.27× | ||
| Q3 24 | — | 1.46× | ||
| Q2 24 | — | -1.59× | ||
| Q1 24 | — | -1.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BBIO
Segment breakdown not available.
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
